Commissioned to celebrate 75 years of the BJC, this special issue looks back on some of the most impactful publications from the journal's long history. The original authors and leading experts giving an overview of the field and important key lessons: https://t.co/gJ1rcK8w0d
Explore a new special issue in @BrJCancer on 'Advances in #ImmuneCheckpointInhibitors use in cancer treatment': https://t.co/0F1RxwoqEu
Read the Editorial article for the collection by Guest Editors Prof Joseph Ciccolini & Dr Gerard Milano: https://t.co/wjJ7zuN59X
Save the date! We are hosting a webinar on Cancer Associated Fibroblasts
🗓️ Wednesday 7th Jun 2023
⏲️ 16.00 PM (Europe/London)
Join us and our speakers @ErezNeta@shouval@Calon_Alex and @FatimaMechta by registering here:
https://t.co/nDUpY2hw5U
@NatResCancer #CancerResearch
Application is now open for the BJC Reports Trainee Editorial Board. Applicants should be early career researchers (postdoctoral), or clinicians and other health professionals on an approved training scheme in a cancer-related discipline: https://t.co/ivrnOeC2Ac
We are delighted to announce that the British Journal of Cancer has launched a new, fully open access partner journal, BJC Reports (https://t.co/DozNbJmyHN).
For pre-submission enquiries and applications to the Editorial Board, please contact us at [email protected].
Digital Imaging: open to receiving submissions assessing:
▪️ State-of-the-art in digital imaging technology and computational output;
▪️ Radiomics;
▪️Algorithms and approaches designed to predict therapeutic response and enable “personalized medicine”
https://t.co/cYVzmKOefL
What's the value of negative data?
A new systematic review of Patient Attrition in Molecular Tumour Boards from our @digital_ECMT (published in @BrJCancer) shows the value of including the data that's normally left out of papers
Read it here: https://t.co/aWRWFCwn1x
@EdinCRC scientists report clinical and histopathological characterisation of the largest pathologically confirmed cohort of ovarian carcinosarcoma patients to date. New insights into this rare form of #ovariancancer! Published in @BrJCancer. Lay summary:
https://t.co/dIMjGN6vWO
👏Excellent review on Liquid biopsies to monitor and direct cancer treatment in colorectal cancer! @BrJCancer
https://t.co/YlTr05APbU
👉Ongoing trials will define the impact of ctDNA for decision making in #CRC@myESMO@OncoAlert
The British Journal of Cancer is seeking an exceptional candidate to serve as Editor-in-Chief of the journal, starting January 1st 2023. For further information on the role please visit: https://t.co/eQ8UOwVvDX. Application deadline: September 2nd 2022.
Inhibition of PFKFB3 in HER2-positive gastric cancer improves sensitivity to trastuzumab by inducing tumour vessel normalisation
Read for free: https://t.co/qJudfwV8MB
TXN inhibitor impedes radioresistance of colorectal cancer cells with decreased ALDH1L2 expression via TXN/NF-κB signaling pathway
#OpenAccess in BJC: https://t.co/Jq5EVIylsX
@zhang_yaowei
POH1/Rpn11/PSMD14: a journey from basic research in fission yeast to a prognostic marker and a druggable target in cancer cells
Read for free: https://t.co/jtaG70f65G
#Drugdevelopment#Molecularmedicine#Oncogenes
HIF-1α stimulates the progression of oesophageal squamous cell carcinoma by activating the Wnt/β-catenin signalling pathway
Read for free using #SharedIt: https://t.co/sNvsMANiAZ
#Cancermicroenvironment#Oncogenes
Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade
Read for free: https://t.co/bN9JTwx28Q
#Cancerstemcells#Metastasis